Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism

PLoS One. 2013 Dec 31;8(12):e85403. doi: 10.1371/journal.pone.0085403. eCollection 2013.

Abstract

Intracellular nicotinamide phosphoribosyltransferase (iNAMPT) in neuron has been known as a protective factor against cerebral ischemia through its enzymatic activity, but the role of central extracellular NAMPT (eNAMPT) is not clear. Here we show that eNAMPT protein level was elevated in the ischemic rat brain after middle-cerebral-artery occlusion (MCAO) and reperfusion, which can be traced to at least in part from blood circulation. Administration of recombinant NAMPT protein exacerbated MCAO-induced neuronal injury in rat brain, while exacerbated oxygen-glucose-deprivation (OGD) induced neuronal injury only in neuron-glial mixed culture, but not in neuron culture. In the mixed culture, NAMPT protein promoted TNF-α release in a time- and concentration-dependent fashion, while TNF-α neutralizing antibody protected OGD-induced, NAMPT-enhanced neuronal injury. Importantly, H247A mutant of NAMPT with essentially no enzymatic activity exerted similar effects on ischemic neuronal injury and TNF-α release as the wild type protein. Thus, eNAMPT is an injurious and inflammatory factor in cerebral ischemia and aggravates ischemic neuronal injury by triggering TNF-α release from glia cells, via a mechanism not related to NAMPT enzymatic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / enzymology
  • Brain Ischemia / enzymology*
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology*
  • Extracellular Space / enzymology*
  • Glucose / metabolism
  • Male
  • Neuroglia / drug effects
  • Neuroglia / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Nicotinamide Phosphoribosyltransferase / pharmacology*
  • Oxygen / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Nicotinamide Phosphoribosyltransferase
  • Glucose
  • Oxygen

Grants and funding

The work was supported by funds from the Ministry of Science and Technology (2013CB910200), the National Natural Sciences Foundation (81072619, 81373392, 81173041, 81272594, 81273491 and 30873053) and Zhejiang Provincial Natural Science Foundation of China (Z2110059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.